The South Asian (SA) population constitutes one of the largest ethnic groups in the world. Several studies that compared host and migrant populations around the world indicate that SAs have a higher risk of developing cardiovascular disease (CVD) than their native-born counterparts. Herein, we review the literature to address the role of the screening tools, scoring systems, and guidelines for primary, secondary, and tertiary prevention in these populations. Management based on screening for the CVD risk factors in a high-risk population such as SAs can improve health care outcomes. There are many scoring tools for calculating 10-year CVD risk; however, each scoring system has its limitations in this particular ethnicity. Further work is needed to establish a unique scoring and guidelines in SAs.
NairMAliMKAjayVS. CARRS Surveillance study: design and methods to assess burdens from multiple perspectives. BMC Public Health. 2012;12:701.
2.
WildSHFischbacherCBrockAGriffithsCBhopalR. Mortality from all causes and circulatory disease by country of birth in England and Wales 2001-2003. J Public Health (Oxf). 2007;29(2):191–198.
3.
AhmedEEl-MenyarA. South Asian Ethnicity and Cardiovascular Risk: The Known, the Unknown, and the Paradox. Angiology. 2015;66(5):405–415. pii: 0003319714541323.
4.
TziomalosKWeerasingheCNMikhailidisDPSeifalianAM. Vascular risk factors in South Asians. Int J Cardiol. 2008;128(1):5–16.
5.
GuptaRJoshiPMohanVReddyKSYusufS. Epidemiology and causation of coronary heart disease and stroke in India. Heart. 2008;94(1):16–26.
6.
EnasEAGargADavidsonMANairVMHuetBAYusufS. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48(4):343–353.
7.
RoglicGUnwinN. Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15–19.
8.
DanaeiGLawesCMMVan der HoornSMurrayCJLEzzatiM. Global and regional mortality from ischemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368(9548):1651–1659.
9.
PaisPPogueJGersteinH. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet. 1996;348(9024):358–363.
10.
AnandSSXieCPareG. Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: the INTERHEART Genetics Study. Circ Cardiovasc Genet. 2009;2(1):16–25.
11.
IqbalRAnandSOunpuuS. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART Study. Circulation. 2008;118(19):1929–1937.
12.
McQueenMJHawkenSWangX. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008;372(9634):224–233.
13.
YusufSHawkenSOunpuuS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364(9438):937–952.
14.
EnasESenthilkumarA. Coronary artery disease in Asian Indians: an update and review. Internet J Cardiol. https://ispub.com/IJC/1/2/4493. Accessed on May 1, 2015.
15.
EnasEAMehtaJ. Malignant coronary artery disease in young Asian Indians: Thoughts on pathogenesis, prevention and treatment. Clin Cardiol. 1995;18(3):131–135.
16.
SilbigerJJSteinRRoyM. Coronary artery disease in South Asian immigrants living in New York City: angiographic findings and risk factor burdens. Ethn Dis. 2013;23(3):292–295.
17.
RajaduraiJArokiasamiJPasamanichanKShatarAMei-LinO. Coronary disease in Asians. Aus NZ J Med. 1992;22(4):345–348.
18.
BahuleyanCG. Hospital data on coronary heart disease from North Kerala. In: VijayaraghavanG ed. Cardiovascular Disease Prevention. Trivandrum, India: Trivandrum Medical College; 1996;54–59.
19.
NegusB HWillardJEGlamannDB. Coronary anatomy and prognosis of young, asymptomatic survivors of myocardial infarction. Am J Med. 1994;96(4):354–358.
20.
HughesLORavalURafteryE. First myocardial infarctions in Asian and White men. BMJ. 1989;298(6684):1345–1350.
21.
HughesKLunKYeoP. Cardiovascular disease in Chinese, Malays and Indians in Singapore: 1. Differences in mortality. J Epidemiol Community Health. 1990;44(1):24–28.
22.
TillinTHughesADMayetJWhincupPSattarNForouhiNG. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -a prospective population-based study. J Am Coll Cardiol. 2013;61(17):1777–1786.
23.
FruchartJCNiermanMCStroesESKasteleinJJDuriezP. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109 (23 suppl 1):III15–III19.
24.
EnasEA. Arresting and reversing the epidemic of CAD among Indians. In: KumarA, ed. Current Perspectives in Cardiology. Chennai: Cardiological Society of India; 2000;109–128.
25.
SatheAFlowersEMathurAGarciaDMKotrysJGandhiR. A culturally specific health coaching program targeting cardiovascular disease risk in South Asians: rationale, design, and baseline data. Ethn Dis. 2013;23(3):304–309.
26.
SelvarajahSHaniffJKaurGGuat HiongTBujangAChee CheongK. Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations. BMC Cardiovasc Disord. 2013;13:10.
27.
PortaM. Dictionary of epidemiology (5thedition). New York: Oxford University Press; 2008. doi:10.1093/acref/9780195314496.001.0001.
28.
LabartheDR. Prevention of cardiovascular risk factors in the first place. Prev Med. 1999;29(6 pt 2): S72–78.
29.
ParadisGChioleroA. The cardiovascular and chronic diseases epidemic in low- and middle-income countries a global health challenge. J Am Coll Cardiol. 2011;57(17):1775–1777.
30.
NiinikoskiHLagstromHJokinenE. Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins: the STRIP study. Circulation. 2007;116(9):1032–1040.
31.
LockKSmithRDDangourAD. Health, agricultural, and economic effects of adoption of healthy diet recommendations. Lancet. 2010;376(9753):1699–1709.
32.
KonesR. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011;5:325–380.
33.
EnasEAJacobS. Decline of CAD in developed countries: Lessons for India. In: SethiK ed. Coronary Artery Disease in Indians – A Global Perspective. Mumbai: Cardiological Society of India; 1998;98–113.
34.
McCrindleBWUrbinaEMDennisonBA. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948–1967.
35.
EnasEA. How to Beat the Heart Disease Epidemic among South Asians: A Prevention and Management Guide for Asian Indians and their Doctors. Downers Grove: Advanced Heart Lipid Clinic. USA; 2011
36.
LimSSGazianoTAGakidouE. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007;370(9604):2054–2062.
37.
AsariaPChisholmDMathersCEzzatiMBeagleholeR. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370(9604):2044–2053.
38.
LonnEBoschJTeoKKPaisPXavierDYusufS. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation. 2010;122(20):2078–2088.
39.
Tunstall-PedoeHVanuzzoDHobbsM. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000;355(9205):688–700.
40.
BeltrameJFDreyerRTavellaR (2012). Epidemiology of Coronary Artery Disease, Coronary Artery Disease-Current Concepts in Epidemiology, Pathophysiology, Diagnostics and Treatment, Dr. David Gaze Ed. In Tech, Web site. http://www.intechopen.com/download/get/type/pdfs/id/32288.
41.
VieraAJSheridanSL. Global risk of coronary heart disease: assessment and application. Am Fam Physician. 2010;82(3):265–274.
42.
SmithSCJr. Current and future directions of cardiovascular risk prediction. Am J Cardiol. 2006;97(2A):28A–32A.
43.
BhopalRFischbacherCVartiainenEUnwinNWhiteMAlbertiG. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf). 2005;27(1):93–100.
44.
Hippisley-CoxJCouplandCVinogradovaYRobsonJMayMBrindleP. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335(7611):136–141.
45.
GoffDCJrLloyd-JonesDMBennettG. American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013 ACC/AHA guideline on the assessment of cardiovascular risk a report of the American College ofCardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S49–S73.
46.
GameFLJonesAF. Ethnicity and risk factors for coronary heart disease in diabetes mellitus. Diabetes Obes Metab. 2000;2(2):91–97.
47.
KoonerJSChambersJC. Conceptualising the causes of coronary heart disease in South Asians. In: PatelKCBhopalRS eds. The Epidemic of Coronary Heart Disease in South Asian Populations: Causes and Consequences. Birmingham: South Asian Health Foundation; 2004;19–47.
48.
QuirkeTPGillPSMantJWAllanTF. The applicability of the Framingham coronary heart disease prediction function to black and minority ethnic groups in the UK. Heart. 2003;89(7):785–786.
49.
GrundySMPasternakRGreenlandPSmithSJrFusterV. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481–1492.
50.
EnasEAKuruvilaAKhannaPPitchumoniCSMohanV. Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians – A population with the highest risk of premature coronary artery disease & diabetes. Indian J Med Res. 2013;138(4):461–491.
51.
RaoNEastwoodSVJainA. Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract. 2012;66(3):262–269.
52.
BrindlePBeswickAFaheyTEbrahimS. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003;327(7426):1267. doi:10.1136/bmj.327.7426.1267.
53.
JacksonRMarshallRKerrARiddellTWellsS. Qrisk or Framingham for predicting cardiovascular risk?BMJ. 2009;339:b2673. doi:10.1136/bmj.b2673.
54.
CooneyMTDudinaALGrahamIM. Value and limitations of existing scores for the assessment of cardiovascular risk. A review for clinicians. J Am Coll Cardiol. 2009;54(14):1209–1227.
55.
Hippisley-CoxJCouplandCVinogradovaY. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of Qrisk2. BMJ. 2008;336(7659):1475–1482.
56.
Full Guideline (82008). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. https://www.nice.org.uk/guidance/cg71(Review decision date: November 2014_). Accessed at 1 May 2015.
57.
CollinsGSAltmanDG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ. 2010;340:c2442. doi:10.1136/bmj.c2442.
58.
DaltonARBottleASoljakMMajeedAMillettC. Ethnic group differences in cardiovascular risk assessment scores: national cross-sectional study. Ethn Health. 2014;19(4):367–384. doi:10.1080/13557858.2013.797568.
59.
BansalMKasliwalRRTrehanN. Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: a study in patients with first myocardial infarction. Indian Heart J. 2014;66(6):580–586.
60.
EnasEASinghVGuptaRPatelR. Recommendations of the Second Indo-US Health Summit for the prevention and control of cardiovascular disease among Asian Indians. Indian Heart J. 2009;61(3):265–274.
61.
SmithSCJrAllenJBlairSN. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363–2372.
62.
EagleKAGuytonRADavidoffR. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110(9):1168–1176.
63.
SharmaKKGuptaRAgrawalA. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Vasc Health Risk Manag. 2009;5:1007–1014.
64.
GuptaRGuptaVAhluwaliaN. Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India. BMJ. 1994;309(6965):1332–1336.
65.
O’KeefeJHMilesJHarrisWMoeRMcCallisterB. Improving the adverse cardiovascular prognosis of Type 2 diabetes. Mayo Clin Proc. 1999;74(2):171–180.
66.
SinghRBGalDNiazMA. The effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients: the Indo-Mediterranean diet heart study. Lancet. 2002;360(9344):1455–1461.
67.
O’MalleyPGJonesDLFeuersteinIMTaylorAJ. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med. 2000;343(18):1298–1304.
68.
WilliamsJ EPatonCCSieglerICEigenbrodtMLNietoFJTyrolerHA. Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study. Circulation. 2000;101(17):2034–2039.
69.
StergiopoulosKBrownDL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(4):312–319.
70.
FerranteDKonfinoJLinetzkyBTambussiALaspiurS. Barriers to prevention of cardiovascular disease in primary care settings in Argentina. Rev Panam Salud Publica. 2013;33(4):259–266.
71.
SpositoACRamiresJAJukemaJW. Physicians’ attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Curr Med Res Opin. 2009;25(5):1171–1178.
72.
LégaréFRattéSGravelKGrahamID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Educ Couns. 2008;73(3):526–535.
73.
GravelKLégaréFGrahamID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implement Sci. 2006;1:16.
74.
YusufSIslamSChowCK. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378(9798):1231–1243.
ChanMY. Clopidogrel pharmacogenetics of east, south and other Asian populations. Eur Heart J Suppl. 2012;14(suppl A):A41–A42.
77.
GurbelPATantryUSShuldinerARKereiakesDJ. Genotyping: one piece of the puzzle to personalize antiplatelet therapy. J Am Coll Cardiol. 2010;56(2):112–116.
78.
MegaJLCloseSLWiviottSD. Cytochrome P450 genetic polymorphisms and the response to prasugrel: Relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation. 2009;119(19):2553–2560.
79.
ShuldinerARO’ConnellJRBlidenKP. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA. 2009;302(8):849–857.
80.
MegaJLCloseSLWiviottSD. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360(4):354–362.
81.
KressinNRPetersenLA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med. 2001;135(5):352–366.
82.
FederGCrookAMMageePBanerjeeSTimmisADHemingwayH. Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography. BMJ. 2002;324(7336):511–516.
83.
GasevicDKhanNAQianHKarimS. Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and White patients with acute myocardial infarction: administrative data analysis. BMC Cardiovasc Disord. 2013;13:121.
84.
YadavaOPArvindPrakashlAnirban KundurMY. Coronary Artery Bypass Grafting in Women -Is OPCAB Mandatory?Indian Heart J. 2011;63(5):425–428.
85.
DhawanJBrayC. Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size estimation during life. Int J Cardiol. 1995;49(3):267–269.
86.
ToorISJaumdallyRLipGY. Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention. Int J Clin Pract. 2011;65(12):1259–1266.
87.
MackayMSinghRBooneR. Ethnicity-based differences in outcomes following percutaneous coronary intervention. Can J Cardiol. 2013;29(10): supp.S281.
88.
JonesDARathodKSSekhriN. Case death rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention. Heart. 2012;98(5):414–419.
89.
JonesDAGallagherSRathodKS. NICOR (National Institute for Cardiovascular Outcomes Research). Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. JACC Cardiovasc Interv. 2014;7(4):362–371.
90.
GoldsmithILipGYHTsangGPatelRL. Comparison of primary coronary artery bypass surgery in a British Indo-Asian and white Caucasian population. Eur Heart J. 1999;20(15):1094–1100.
91.
ZindrouDPeder BaggerJSmithPTaylorKMRatnatungaCP. Comparison of operative mortality after coronary artery bypass grafting in Indian subcontinent Asians versus Caucasians. Am J Cardiol. 2001;88(3):313–316.
92.
BristerSJHamdulayZVermaSMagantiMBuchananMR. Ethnic diversity: South Asian ethnicity is associated with increased coronary artery bypass grafting mortality. J Thorac Cardiovasc Surg. 2007;133(1):150–154.
93.
HadjinikolaouLKlimatsidasMIaconaGMSpytTSamaniNJ. Short- and medium-term survival following coronary artery bypass surgery in British Indo-Asian and white Caucasian individuals: impact of diabetes mellitus. Interact Cardiovasc Thorac Surg. 2010;10(3):389–393.
94.
MartinBNorrisCSouthernDAQuanHAliIMBaineyKR. Calgary, Alberta. The association between South Asian ethnicity and long-term survival among patients undergoing coronary artery bypass grafting. Can J Cardiol. 2012;28(5 S):S122–S123.
95.
KailaKSNorrisCMGrahamMMAliIBaineyKR. Long-term survival with revascularization in South Asians admitted with an acute coronary syndrome (from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease Registry). Am J Cardiol. 2014;114(3):395–400.
96.
KhanNAGrubisicMHemmelgarnBHumphriesKKingKMQuanH. Outcomes after acute myocardial infarction in South Asian, Chinese, and white patients. Circulation. 2010;122(16):1570–1577.
97.
QuanHKhanNLiLing. Invasive cardiac procedure use and mortality among South Asian and Chinese Canadians with coronary artery disease. Can J Cardiol. 2010;26(7):e236–e242.
98.
MakKHKarkJDChiaKSTanCFoongBHChewSK. Ethnic differences in utilization of invasive cardiac procedures and in long-term survival following acute myocardial infarction. Clin Cardiol. 2004;27(5):275–280.
